FDA Approved: REZDIFFRA — Original Application (Madrigal Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved REZDIFFRA (resmetirom) from Madrigal Pharmaceuticals for the treatment of nonalcoholic steatohepatitis with fibrosis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• REZDIFFRA (RESMETIROM)

Snippet

ORIG AP for REZDIFFRA (RESMETIROM)